BIMI International Medical

BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines (“TCM”), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in Chongqing, China.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines (“TCM”), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in New York, NY.

New York, April  21, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Memorandum of Understanding (“MOU”) with its wholly-owned subsidiary, BOYI technology, and Dalian Shengshi Nianhua Hospital to develop a telemedicine system for hospitals.

BOQI International Medical Enters into MOU with Dalian Shengshi Nianhua Hospital to Develop Telemedicine System

New York, April  01, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a stock purchase agreement to spin off its energy business.

BOQI International Medical Announces Stock Purchase Agreement to Spin Off its Energy Business

New York, March  27, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that its wholly-owned subsidiary, Chongqing Guanzan Technology Co., Ltd. (“Chongqing Guanzan”), has entered into a $10 million medical device purchase agreement with Chongqing Kegemo Biotechnology Co., Ltd. (“Chongqing Kegemo”).

BOQI International Medical Announces $10 Million Medical Device Purchase Agreement with Chongqing Kegemo Biotechnology

New York, March  20, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that its wholly-owned subsidiary, Chongqing Guanzan Technology Co., Ltd. (“Chongqing Guanzan”), has entered into a $19 million medical device purchase agreement with Shandong Forward Medical Group Co., Ltd. (“Shandong Forward Medical”).

BOQI International Medical Announces $19 Million Medical Device Purchase Agreement with Shandong Forward Medical Group

New York, March  19, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has completed the acquisition of Chongqing Guanzan Technology Co., Ltd. (“Chongqing Guanzan”).

BOQI International Medical Completes Acquisition of Chongqing Guanzan Technology

New York, March  06, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced update of its membership program with more exclusive benefits. The company is also expanding its supply chains to ensure the customers have access to medical supplies during this time of need.  On March 5, 2020, the Company entered into a purchase agreement with Nanjing Chuangling Environmental Technology Co., Ltd. (“Nanjing Chuangling”) through its wholly-owned subsidiary Boqi Zhengji Pharmacy Chain Co., Ltd. According to the agreement, Nanjing Chuangling is going to supply surgical masks and 75% rubbing alcohol to Boqi Zhengji Pharmacy’s multiple chain stores. The company agreed to purchase 1,000,000 surgical masks and 100,000 bottles of 75% rubbing alcohol in total. The first batch of 10,000 surgical masks and 1,000 bottles of 75% rubbing alcohol is expected to be delivered on or before March 15, 2020.

BOQI International Medical Updates Membership Program with Exclusive Benefits

New York, March  02, 2020  (GLOBE NEWSWIRE) --  BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that the Company has entered into a distributorship agreement with Chongqing Harmony Pharmaceutical Co, Ltd. (“Harmony”). BOQI International Medical is authorized as the exclusive distributor of Harmony’s Seradase Serrapeptase Enteric-coated Tablets(“Seradase”)  in Southwest China. 

BOQI International Medical Announces Distributorship Agreement for Seradase in Southwest China

New York, Feb.  18, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the appointment of Mr. Xiaoping Wang as Chief Operating Officer (“COO”). As COO, Mr. Wang has responsibility for the company's supply chain and sourcing operations, demand planning, distribution, information technology, business process management, corporate real estate, asset protection and sustainability.

BOQI International Medical Announces Xiaoping Wang As Chief Operating Officer

New York, Feb.  11, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the formation and business plan of its new wholly-owned subsidiary, BOYI Technology, a healthcare technology company focused on developing and marketing Telehealth software, eProcurement platform and supply-chain-management software (SCMS) for the healthcare industry.

BOQI International Medical Forms New Subsidiary, BOYI Technology, To Generate Revenue In Healthcare Technology Industry

New York, Feb.  07, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed an Amendment to Stock Purchase Agreement for the acquisition of Boqi Zhengji Pharmacy Chain Co., Ltd (“Boqi Pharmacy”) (the “Amendment”). The Amendment contemplates substantial changes to the mechanism for the adjustment to the post-closing consideration.

BOQI International Medical Amends Terms for Acquisition of Boqi Zhengji Pharmacy Chain

New York, Feb.  04, 2020  (GLOBE NEWSWIRE) -- In a release issued under the same headline on Monday, February 3, 2020 by BOQI International Medical Inc. (NASDAQ: BIMI), in the third paragraph, the Cash Consideration to be paid should have been RMB 80,000,000 (currently approximately $11,428,571), not RMB 800,000,000. The corrected release follows:

Correction: BOQI International Medical Enters into Material Definitive Agreement to Acquire Chongqing Guanzan Technology

New York, Feb.  03, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a stock purchase agreement (the “Agreement”) to acquire Chongqing Guanzan Technology Co., Ltd., (“Chongqing Guanzan”) through its wholly-owned subsidiary Beijing Xin Rong Xin Industrial Development Co., Ltd. (“Buyer”)

BOQI International Medical Enters into Material Definitive Agreement to Acquire Chongqing Guanzan Technology

New York, Jan.  29, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc., previously known as NF Energy Saving Corporation (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced actions against the novel coronavirus.

BOQI International Medical Announces Actions Against Novel Coronavirus

New York, Jan.  14, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc., previously known as NF Energy Saving Corporation (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that on Jan. 13, 2020, it had signed a Memorandum of Understanding (“MOU”) with Lasting Wisdom Holdings Limited’s former shareholders Yu Zhang, Yunpeng Liu, Aiguo Leng, Xiaona Liu, and Peng Zhao to renegotiate purchase price for Boqi Zhengji Pharmacy Chain Co., Ltd. (“Boqi Zhengji Pharmacy Chain”) to reduce the cost of the acquisition.

BOQI International Medical Renegotiates Purchase Price For Boqi Zhengji Pharmacy Chain Co., Ltd.

New York, Dec.  20, 2019  (GLOBE NEWSWIRE) -- NF Energy Saving Corporation (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced its company name change to BOQI International Medical Inc. effective Dec. 16, 2019. The Company’s ordinary shares will continue to trade under the symbol “BIMI”.

NF Energy Saving Corporation Announces Company Name Change To BOQI International Medical Inc.

News for BIMI International Medical Stock (BIMI)